Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases.
作者信息
Ryan John G, Aksentijevich Ivona
出版信息
Arthritis Rheum. 2009 Jan;60(1):8-11. doi: 10.1002/art.24145.
Abstract
摘要
相似文献
1
Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases.
Arthritis Rheum. 2009 Jan;60(1):8-11. doi: 10.1002/art.24145.
2
Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Arthritis Rheum. 2009 Jan;60(1):269-80. doi: 10.1002/art.24147.
3
Tumor necrosis factor receptor-associated periodic syndrome with a C30R mutation in a Japanese family.
Mod Rheumatol. 2007;17(3):265-6. doi: 10.1007/s10165-007-0580-0. Epub 2007 Jun 20.
4
The hereditary autoinflammatory syndromes.
Pediatr Infect Dis J. 2007 Apr;26(4):353-4. doi: 10.1097/01.inf.0000258777.86510.da.
5
The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
Expert Rev Mol Med. 2005 Oct 10;7(22):1-18. doi: 10.1017/S1462399405009749.
6
Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever.
Curr Opin Rheumatol. 2006 Jan;18(1):108-17. doi: 10.1097/01.bor.0000198006.65697.5b.
7
Autoinflammatory syndromes with a dermatological perspective.
J Dermatol. 2007 Sep;34(9):601-18. doi: 10.1111/j.1346-8138.2007.00342.x.
8
Heparin serves as a natural stimulant of the inflammasome and exacerbates the symptoms of tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
J Dermatol Sci. 2012 Apr;66(1):82-4. doi: 10.1016/j.jdermsci.2011.11.006. Epub 2011 Nov 25.
9
Autoinflammatory diseases: clinical and genetic advances.
Arch Dermatol. 2008 Mar;144(3):392-402. doi: 10.1001/archderm.144.3.392.
10
Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6-10 November 2005.
Ann Rheum Dis. 2006 Jul;65(7):961-4. doi: 10.1136/ard.2006.052688. Epub 2006 Apr 10.
引用本文的文献
1
Autoinflammatory diseases: what is behind them and what is new?
Dermatol Reports. 2022 Dec 29;15(2):9625. doi: 10.4081/dr.2023.9625. eCollection 2023 Jun 7.
2
Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS).
Front Immunol. 2019 Nov 26;10:2756. doi: 10.3389/fimmu.2019.02756. eCollection 2019.
3
Tumor necrosis factor-associated periodic syndrome in adults.
Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23.
4
Understanding the conservation patterns and molecular phylogenetics of human death receptors family through computational biology.
3 Biotech. 2014 Apr;4(2):177-187. doi: 10.1007/s13205-013-0141-5. Epub 2013 May 25.
5
Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation.
J Biol Chem. 2011 Nov 11;286(45):38980-8. doi: 10.1074/jbc.M111.277087. Epub 2011 Sep 23.
6
The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.
PLoS One. 2011 Apr 28;6(4):e18813. doi: 10.1371/journal.pone.0018813.
7
[Autoinflammatory syndromes/fever syndromes].
Hautarzt. 2011 May;62(5):389-401; quiz 402. doi: 10.1007/s00105-010-2124-3.
8
Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey.
Pediatr Rheumatol Online J. 2010 Dec 2;8:29. doi: 10.1186/1546-0096-8-29.
9
[Periodic fever syndrome/autoinflammatory syndrome].
Z Rheumatol. 2009 Mar;68(2):137-48; quiz 149. doi: 10.1007/s00393-009-0449-z.
本文引用的文献
1
Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Arthritis Rheum. 2009 Jan;60(1):269-80. doi: 10.1002/art.24147.
2
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.
Arthritis Rheum. 2008 May;58(5):1516-20. doi: 10.1002/art.23475.
3
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
Rheumatology (Oxford). 2007 Dec;46(12):1865-6. doi: 10.1093/rheumatology/kem231. Epub 2007 Oct 29.
4
Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
Arthritis Rheum. 2007 Aug;56(8):2765-73. doi: 10.1002/art.22740.
5
Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
Arthritis Rheum. 2006 Aug;54(8):2674-87. doi: 10.1002/art.21964.
6
Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).
Blood. 2006 Aug 15;108(4):1320-7. doi: 10.1182/blood-2005-11-006783. Epub 2006 May 9.
7
Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression.
FEBS Lett. 2005 Sep 26;579(23):5193-8. doi: 10.1016/j.febslet.2005.08.037.
8
Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.
Arthritis Rheum. 2005 Apr;52(4):1287-92. doi: 10.1002/art.20955.
9
Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
Arthritis Rheum. 2004 Aug;50(8):2651-9. doi: 10.1002/art.20380.
10
Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Immunology. 2004 Sep;113(1):65-79. doi: 10.1111/j.1365-2567.2004.01942.x.
Zotero 插件